Clinical Trials Directory

Trials / Completed

CompletedNCT01009658

MSG and Gastrointestinal Motility

Effect of Monosodium Glutamate on Upper Gastrointestinal Tract Motility

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Gunma University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to clarify the physiological function of sodium glutamate by measuring its effect on upper GI motility ( gastric emptying).

Detailed description

Amino acids such as monosodium glutamate are known to stimulate both endocrine and exocrine secretion. In addition, there is a report that oral intake of glutamate evokes the activation of vagal afferent nerves in the rat. Thus, such amino acids are thought to be influential in the process of digestion and absorption. . To investigate the effect of monosodium glutamate on gastrointestinal motility, we planned a single-blind randomized study. The participants will take either monosodium glutamate or sodium chloride before the first examination of upper GI motility and the other agent before the second examination. The order of intake will be randomized by the envelope method.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMonosodium glutamateOral intake of 2.0 g of monosodium glutamate on the examination day and 0.6 g of sodium chloride on the other examination day.
DIETARY_SUPPLEMENTSodium chlorideOral intake of 0.6 g of sodium chloride on the examination day and 2.0 g of monosodium glutamate on the other examination day.

Timeline

Start date
2009-12-01
Primary completion
2015-03-01
First posted
2009-11-09
Last updated
2015-03-26

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT01009658. Inclusion in this directory is not an endorsement.